| CONTEXT THERAPEUTICS |
| USA |
| Gesundheit |
| US21077P1084 / A3CWBU |
| 6K9 (Frankfurt) / CNTX (NASDAQ) |
| FRA:6K9, ETR:6K9, 6K9:GR, NASDAQ:CNTX |
| - |
| https://www.contexttherap.. |
|
Context Therapeutics Inc. is a biopharmaceutical company focused on advancing treatments for hormone-driven female cancers. Primarily, the company develops investigational therapies targeting estrogen receptors, aiming to innovate in areas of signifi..
>Volltext.. |
| 194.63 Mio. EUR |
| 139.04 Mio. EUR |
| - |
| -34.29 Mio. EUR |
| -31.23 Mio. EUR |
| -0.33 EUR |
| 0.1 Mio. EUR |
| 57.06 Mio. EUR |
| -22.81 Mio. EUR |
| 8.23 |
| - |
| -19.14% |
| - |
| - |
| - |
| - |
| CONTEXT THERAPEUTICS, CONTEXT THERAPEUTIC |
| 02.04.26 |
|
||||
|
||||
|
||||
|